Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bruce J DezubeP S Gill

Abstract

Angiogenesis is a major component of Kaposi's sarcoma (KS) and a critical process in tumor growth. The present study was designed primarily to test the toxicity and pharmacokinetics (PK) of the angiogenesis inhibitor TNP-470 and secondarily to evaluate tumor response in patients with early AIDS-related KS. Patients with AIDS-related KS were required to have cutaneous disease with > or = 5 measurable lesions and no evidence of pulmonary, symptomatic gastrointestinal, or acutely life-threatening KS. Thirty-eight patients received TNP-470 by weekly intravenous infusion over 1 hour at one of six dose levels for up to 24 weeks. The dose levels tested included 10, 20, 30, 40, 50 and 70 mg/m2. Median CD4 count was 24 cells/microl (range, 0 to 460). Fourteen patients (36%) had > or = 50 cutaneous lesions and 19 (49%) had oral lesions. Adverse events included neutropenia (n = 2), hemorrhage (n = 3), and urticaria (n = 1). PK studies showed wide interpatient and intrapatient variability. Elimination half-life values were short (range, 0.01 to 0.61 hours). Seven patients (18%) achieved a partial response. The median time to partial response was 4 weeks (range, 2 to 25), and the median duration of response was 11 weeks (range, 3 to 26+). T...Continue Reading

Citations

Mar 20, 1999·Current Opinion in Pediatrics·J B Rubin, M W Kieran
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W M StadlerN J Vogelzang
Nov 11, 1999·Medizinische Klinik·D SchieferA Engert
Dec 21, 2000·Current Oncology Reports·T R TennantW M Stadler
Jun 29, 2001·Current Opinion in Oncology·J V Heymach
Jun 21, 2002·The New England Journal of Medicine·Jean-Michel MolinaUNKNOWN Agence Nationale de Recherches sur le SIDA 090 Study Group
Jul 2, 2005·Expert Opinion on Emerging Drugs·K J O'Byrne, W P Steward
May 27, 2005·Organic & Biomolecular Chemistry·Ralph MazitschekAthanassios Giannis
May 25, 2006·Current Opinion in Oncology·Lakshmi Balasubramanian, Andrew M Evens
Dec 25, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Dongxiao YaoXianli Zhu
Apr 27, 2011·Expert Opinion on Pharmacotherapy·Cecilia SgadariBarbara Ensoli
Sep 7, 2000·Current Opinion in Oncology·B J Dezube
Apr 6, 2000·Current Opinion in Oncology·R T Mitsuyasu
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R F LittleR Yarchoan
Apr 24, 2007·Acta Oncologica·Kanlayanee SawanyawisuthSopit Wongkham
Aug 6, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wen-Long WangBainian Feng
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A TulpuleP S Gill
Dec 1, 2001·Expert Opinion on Biological Therapy·T G Zogakis, S K Libutti
May 3, 2006·Medicinal Research Reviews·Ana R QuesadaMiguel A Medina
Jul 16, 2005·Hematology·Soon Thye Lim, Alexandra M Levine
Aug 16, 2002·American Journal of Clinical Dermatology·Anna M CattelanSavina M L Aversa
Jan 15, 2003·Annual Review of Medicine·David T Scadden
Dec 17, 2003·The Journal of Biological Chemistry·Cathleen M Brdlik, Craig M Crews
Aug 7, 2007·Expert Review of Anti-infective Therapy·Benjamin LefkoveJack L Arbiser
Mar 21, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S UldrickRobert Yarchoan
May 30, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Susan E KrownMarcia A Testa
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·W T LowtherB W Matthews
Oct 16, 2004·Expert Review of Anti-infective Therapy·Yoshiyasu Aoki, Giovanna Tosato
Oct 3, 2002·Nature Reviews. Cancer·Robert Kerbel, Judah Folkman
Jun 21, 2015·Biochemical and Biophysical Research Communications·Takayuki KannoHarutaka Katano
Nov 26, 2009·Journal of Medicinal Chemistry·Christopher C Arico-MuendelKerry F White
Aug 26, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G Deplanque, A L Harris
Jun 22, 2001·Critical Reviews in Oncology/hematology·P A Burke, S J DeNardo
Mar 10, 2000·Biochimica Et Biophysica Acta·W T Lowther, B W Matthews
May 18, 2000·Cancer Treatment Reviews·M M EatockS B Kaye
Feb 19, 2005·Critical Reviews in Oncology/hematology·Savina Maria Lucia AversaSilvio Monfardini
Jan 7, 2003·Hematology/oncology Clinics of North America·Kerim Kaban, Roy S Herbst
Apr 12, 2003·Neuroimaging Clinics of North America·Michael J Fisher, Peter C Adamson
Jan 3, 2006·Biochimica Et Biophysica Acta·Ponniah SelvakumarRajendra K Sharma
Jun 19, 2007·Survey of Ophthalmology·Bennie H JengDavid M Meisler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
G NastiU Tirelli
World Journal of Clinical Oncology
Pasquale RescignoGiuseppe Di Lorenzo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Mary CianfroccaBruce J Dezube
© 2022 Meta ULC. All rights reserved